0001127602-20-031074.txt : 20201210
0001127602-20-031074.hdr.sgml : 20201210
20201210162501
ACCESSION NUMBER: 0001127602-20-031074
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201209
FILED AS OF DATE: 20201210
DATE AS OF CHANGE: 20201210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Berge Terence M
CENTRAL INDEX KEY: 0001635424
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39218
FILM NUMBER: 201380895
MAIL ADDRESS:
STREET 1: C/O CONMED CORPORATION
STREET 2: 525 FRENCH ROAD
CITY: UTICA
STATE: NY
ZIP: 13502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONMED CORP
CENTRAL INDEX KEY: 0000816956
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 160977505
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 FRENCH ROAD
CITY: UTICA
STATE: NY
ZIP: 13502
BUSINESS PHONE: 315-624-3208
MAIL ADDRESS:
STREET 1: 525 FRENCH ROAD
CITY: UTICA
STATE: NY
ZIP: 13502
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-12-09
0000816956
CONMED CORP
CNMD
0001635424
Berge Terence M
C/O CONMED CORPORATION
525 FRENCH ROAD
UTICA
NY
13502
1
VP-Corporate Controller
Common Stock
2020-12-09
4
S
0
2870
100.64
D
3042
D
Common Stock
2020-12-09
4
S
0
2038
101.43
D
1004
D
Common Stock
2020-12-09
4
M
0
5400
59.96
A
6404
D
Common Stock
2020-12-09
4
S
0
4593
100.387
D
1811
D
Common Stock
2020-12-09
4
S
0
807
101.47
D
1004
D
Options To Purchase Common Stock
59.96
2020-12-09
4
M
0
5400
0
D
2028-03-01
Common Stock
5400
8100
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.27 to $100.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.04 to $101.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.94. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.06 to $101.70. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
/s/ Sarah M. Oliker for Terence M. Berge by Power of Attorney
2020-12-10